BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Xu J, Zhang W, Chen J, Zhou X, Li Z, Han X. Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma. Acad Radiol 2020;27:704-9. [PMID: 31375353 DOI: 10.1016/j.acra.2019.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang M, Sun L, Han X, Ren J, Li H, Wang W, Xu W, Liang C, Duan X. The addition of camrelizumab is effective and safe among unresectable hepatocellular carcinoma patients who progress after drug-eluting bead transarterial chemoembolization plus apatinib therapy. Clin Res Hepatol Gastroenterol 2023;47:102060. [PMID: 36473631 DOI: 10.1016/j.clinre.2022.102060] [Reference Citation Analysis]
2 Liu Z, Kan X, Zhang L, Makamure J, Li Q, Zhao D, Zhou G, Feng G, Zheng C, Liang B. Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors. CURR MED SCI 2022. [DOI: 10.1007/s11596-022-2620-6] [Reference Citation Analysis]
3 Wu W, He X, Yi Z, Zhu Z, He J, Wang W, Zhao C. Flexural fatigue behaviors of high-content hybrid fiber-polymer concrete. Construction and Building Materials 2022;349:128772. [DOI: 10.1016/j.conbuildmat.2022.128772] [Reference Citation Analysis]
4 Fan W, Zhu B, Zheng X, Yue S, Lu M, Fan H, Qiao L, Li F, Yuan G, Wu Y, Zou X, Wang H, Xue M, Li J. Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization. J Cancer Res Clin Oncol 2022. [PMID: 35788728 DOI: 10.1007/s00432-022-04107-w] [Reference Citation Analysis]
5 Li N, Chen J. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients. Ir J Med Sci 2022. [PMID: 35083645 DOI: 10.1007/s11845-021-02884-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ju S, Wang W, Chen P, Li F, Li H, Wang M, Han X, Ren J, Duan X. Drug-eluting bead transarterial chemoembolization followed by apatinib is effective and safe in treating hepatocellular carcinoma patients with BCLC stage C. Clin Res Hepatol Gastroenterol 2022;:101859. [PMID: 34999249 DOI: 10.1016/j.clinre.2022.101859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ouyang T, Liu J, Shi C, Zhu L, Guo X. Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study. J Hepatocell Carcinoma 2021;8:1459-71. [PMID: 34858890 DOI: 10.2147/JHC.S338309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chen L, Sun T, Wu L, Zhang W, Ren Y, Xiang D, Liang B, Zheng C. The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma. J Oncol 2021;2021:8169012. [PMID: 34840572 DOI: 10.1155/2021/8169012] [Reference Citation Analysis]
9 Liu J, Zhang W, Ren J, Li Z, Lu H, Sun Z, Han X. Efficacy and Safety of Drug-Eluting Bead Bronchial Arterial Chemoembolization Plus Anlotinib in Patients With Advanced Non-small-Cell Lung Cancer. Front Cell Dev Biol 2021;9:768943. [PMID: 34778275 DOI: 10.3389/fcell.2021.768943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li H, Wang M, Chen P, Li F, Kuang D, Han X, Ren J, Duan X. Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial Chemoembolization. Onco Targets Ther 2021;14:4659-70. [PMID: 34511935 DOI: 10.2147/OTT.S297523] [Reference Citation Analysis]
11 Li Z, Chen Q, Zhang W, Si G, Li J, Jiao D, Han X. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2021;2021:5565793. [PMID: 34458205 DOI: 10.1155/2021/5565793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Liu J, Zhang W, Lu H, Li H, Zhou X, Li J, Han X. Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value. J Cancer Res Clin Oncol 2021. [PMID: 34405295 DOI: 10.1007/s00432-021-03760-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang W, Chen L, Cao Y, Sun B, Ren Y, Sun T, Zheng C. Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma. Cancer Manag Res 2021;13:5391-402. [PMID: 34262347 DOI: 10.2147/CMAR.S314762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Xia H, Zhou C, Luo Z, Zhang P, Zhu L, Gong Z. Apatinib-Induced Hand-Foot Skin Reaction in Chinese Patients With Liver Cancer. Front Oncol 2021;11:624369. [PMID: 33981598 DOI: 10.3389/fonc.2021.624369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Rivoceranib. Reactions Weekly 2020;1805:268-268. [DOI: 10.1007/s40278-020-78978-2] [Reference Citation Analysis]
16 Cao WZ, Zhou ZQ, Jiang S, Li H, Niu W, Gao P, Li GJ, Chen F. Efficacy and safety of drug-eluting beads for transarterial chemoembolization in patients with advanced hepatocellular carcinoma. Exp Ther Med 2019;18:4625-30. [PMID: 31798699 DOI: 10.3892/etm.2019.8163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]